Page last updated: 2024-08-26

1,4-dihydropyridine and Parkinson Disease

1,4-dihydropyridine has been researched along with Parkinson Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Friis, S; Olsen, JH; Qian, L; Rhodes, SL; Ritz, B; Schernhammer, E1
Guzman, JN; Ilijic, E; Kondapalli, J; Sanchez-Padilla, J; Schumacker, PT; Surmeier, DJ; Wokosin, D1

Other Studies

2 other study(ies) available for 1,4-dihydropyridine and Parkinson Disease

ArticleYear
L-type calcium channel blockers and Parkinson disease in Denmark.
    Annals of neurology, 2010, Volume: 67, Issue:5

    Topics: Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Community Health Planning; Denmark; Dihydropyridines; Female; Humans; Logistic Models; Male; Middle Aged; Outpatients; Parkinson Disease; Prescription Drugs; Registries; Retrospective Studies

2010
Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1.
    Nature, 2010, Dec-02, Volume: 468, Issue:7324

    Topics: Animals; Biological Clocks; Brain; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Signaling; Cyclophilins; Dihydropyridines; Dopamine; Gene Deletion; Ion Channels; Iridoid Glycosides; Iridoids; Male; Mice; Mice, Transgenic; Mitochondria; Mitochondrial Proteins; Neurons; Oncogene Proteins; Oxidative Stress; Parkinson Disease; Peptidyl-Prolyl Isomerase F; Peroxiredoxins; Protein Deglycase DJ-1; Purines; Superoxides; Uncoupling Protein 1

2010